Victory Capital Management
MYOV

Victory Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Victory Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,709,225
Closed -$47.2M – 2783
2020
Q4 		$47.2M Sell
1,709,225
-74,694
-4% -$1.45M 0.05% 540
2020
Q3 		$25.1M Sell
1,783,919
-104,774
-6% -$1.95M 0.03% 700
2020
Q2 		$38.9M Sell
1,888,693
-542,788
-22% -$7.38M 0.05% 509
2020
Q1 		$18.4M Sell
2,431,481
-37,242
-2% -$418K 0.03% 699
2019
Q4 		$38.3M Sell
2,468,723
-229,844
-9% -$2.32M 0.05% 586
2019
Q3 		$14M Buy
2,698,567
+426,554
+19% +$3.16M 0.02% 905
2019
Q2 		$20.6M Buy
2,272,013
+1,429,770
+170% +$21.3M 0.04% 607
2019
Q1 		$20.1M Buy
+842,243
New +$17.2M 0.05% 569

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Victory Capital Management's MYOV Position: Q1 2021 in Review

Victory Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2021, closing a stake of 1,709,225 shares — an estimated $47.2M sold.

Victory Capital Management first reported a position in MYOV in Q1 2019 and held it in 8 quarters. The position peaked at $47.2M in Q4 2020. 104 funds tracked by Wall St. Rank hold MYOV as of Q1 2021.

  • Victory Capital Management reported no remaining Myovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Victory Capital Management sold 1,709,225 Myovant Sciences Ltd. shares in Q1 2021, an estimated $47.2M.
  • Victory Capital Management first reported a position in Myovant Sciences Ltd. in Q1 2019 and held it in 8 quarters.
  • Victory Capital Management's Myovant Sciences Ltd. position peaked at $47.2M in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2021.

Based on Victory Capital Management's 13F filing for Q1 2021, filed 4 May 2021.